![Nithya Desikan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nithya Desikan
Direktor/Vorstandsmitglied bei
PARATEK PHARMACEUTICALS, INC.
Profil
Nithya Desikan is currently Director at Corium LLC, Director at Paratek Pharmaceuticals, Inc., and Operating Partner at Gurnet Point Capital LLC.
Former roles include Vice President at Biogen, Inc. from 2016 to 2017, Chief Commercial Officer at Rhythm Pharmaceuticals, Inc. from 2017 to 2020, and Operating Partner at B Flexion Advisors UK LLP from 2022 to 2026.
Education includes undergraduate studies at the University of Florida.
Aktive Positionen von Nithya Desikan
| Unternehmen | Position | Beginn |
|---|---|---|
| PARATEK PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | - |
Corium LLC
 Corium LLC BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in the development and commercialization of novel neuroscience therapies | Direktor/Vorstandsmitglied | - |
Gurnet Point Capital LLC
 Gurnet Point Capital LLC Investment ManagersFinance Gurnet Point Capital invests in companies located in the United States. The firm targets companies operating in the fields of life sciences and medical technologies sector. It provides financing for buyout stage capital requirements. It also acquires majority stake and control positions. | Private Equity Investor | - |
Ehemalige bekannte Positionen von Nithya Desikan
| Unternehmen | Position | Ende |
|---|---|---|
Northill Capital LLP
 Northill Capital LLP Investment ManagersFinance B Flexion Advisors invests in companies located in the United Kingdom. The firm focuses on life sciences, healthcare services and digital health sectors. It participates in seed and buyout transactions. | Private Equity Investor | 01.06.2026 |
| RHYTHM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 30.09.2020 |
| BIOGEN INC. | Corporate Officer/Principal | 01.07.2017 |
Ausbildung von Nithya Desikan
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
29
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Rhythm Pharmaceuticals, Inc.
 Rhythm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and supplies peptide therapeutics for rare neuroendocrine diseases | Health Technology |
University of Florida
 University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northill Capital LLP
Northill Capital LLP Investment ManagersFinance B Flexion Advisors invests in companies located in the United Kingdom. The firm focuses on life sciences, healthcare services and digital health sectors. It participates in seed and buyout transactions. | Finance |
Paratek Pharmaceuticals, Inc.
 Paratek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Gurnet Point Capital LLC
Gurnet Point Capital LLC Investment ManagersFinance Gurnet Point Capital invests in companies located in the United States. The firm targets companies operating in the fields of life sciences and medical technologies sector. It provides financing for buyout stage capital requirements. It also acquires majority stake and control positions. | Finance |
Corium LLC
Corium LLC BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in the development and commercialization of novel neuroscience therapies | Health Technology |
